These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14525892)

  • 21. Polypill remains the only panacea in sight for cardiovascular disease, trial organiser says.
    Hawkes N
    BMJ; 2012 Jul; 345():e4837. PubMed ID: 22807080
    [No Abstract]   [Full Text] [Related]  

  • 22. The Polypill in the prevention of cardiovascular disease.
    Wald DS; Wald NJ
    Prev Med; 2011 Jan; 52(1):16-7. PubMed ID: 21130112
    [No Abstract]   [Full Text] [Related]  

  • 23. A cardioprotective "polypill"? Independent and additive benefits of lifestyle modification.
    Franklin BA; Kahn JK; Gordon NF; Bonow RO
    Am J Cardiol; 2004 Jul; 94(2):162-6. PubMed ID: 15246891
    [No Abstract]   [Full Text] [Related]  

  • 24. The polypill in the primary prevention of cardiovascular disease.
    Wald DS; Wald NJ
    Fundam Clin Pharmacol; 2010 Feb; 24(1):29-35. PubMed ID: 20002198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiovascular polypill in high risk patients].
    Lafeber M; Spiering W; Bots ML; de Valk V; Visseren FL; Grobbee DE
    Ned Tijdschr Geneeskd; 2011; 155(44):A3070. PubMed ID: 22067559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The polypill: not an effective strategy for reduction of cardiovascular disease].
    Westerweel PE; van Wijk JP; Verhaar MC
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1741. PubMed ID: 16114291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. News of the polypill.
    Marshall T
    BMJ; 2008 Oct; 337():a2160. PubMed ID: 18936068
    [No Abstract]   [Full Text] [Related]  

  • 28. "Polypill-aspostatinoprilololazide folate"--coprescription for at the risk Asian Indian in chronic non communicable diseases.
    Joshi SR
    J Assoc Physicians India; 2005 Mar; 53():175-8. PubMed ID: 15926597
    [No Abstract]   [Full Text] [Related]  

  • 29. [The polypill--an alternative concept in cardiovascular prophylaxis].
    Sandli OK; Spigset O; Slørdal L
    Tidsskr Nor Laegeforen; 2014 Mar; 134(6):632-4. PubMed ID: 24670513
    [No Abstract]   [Full Text] [Related]  

  • 30. The future of metabolic syndrome and cardiovascular disease prevention: polyhype or polyhope? Tales from the polyera.
    Franco OH; Karnik K; Bonneux L
    Horm Metab Res; 2007 Sep; 39(9):627-31. PubMed ID: 17846968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of cardiovascular diseases with multiple risk factors based on "Polypill" concepts].
    Guo XY; Zhao D
    Zhonghua Nei Ke Za Zhi; 2010 Nov; 49(11):909-11. PubMed ID: 21211200
    [No Abstract]   [Full Text] [Related]  

  • 32. A polypill is the solution to the pharmacological management of cardiovascular risk: yes.
    Elley CR
    J Prim Health Care; 2009 Sep; 1(3):232-4. PubMed ID: 20690388
    [No Abstract]   [Full Text] [Related]  

  • 33. A polypill for secondary prevention: time to move from intellectual debate to action.
    Fuster V; Sanz G
    Nat Clin Pract Cardiovasc Med; 2007 Apr; 4(4):173. PubMed ID: 17380163
    [No Abstract]   [Full Text] [Related]  

  • 34. A look at the polypill story 10 years later.
    Wilkinson E
    Eur Heart J; 2013 Jul; 34(27):2019-20. PubMed ID: 23853173
    [No Abstract]   [Full Text] [Related]  

  • 35. [The Polypill: between myths and reality in the treatment of type 2 diabetes mellitus].
    Ruiz J; Egli M
    Rev Med Suisse; 2006 May; 2(68):1480-2, 1484-5. PubMed ID: 16783994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospects and possible pitfalls of a preventive Polypill: confessions of a health promotion convert.
    Green LW
    Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S4-8; discussion S9. PubMed ID: 16052194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polypill: chimera or reality?
    Sanz G; Castellano JM; Fuster V
    Rev Esp Cardiol (Engl Ed); 2014 Sep; 67(9):689-92. PubMed ID: 25172063
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular disease stoppable in developing countries?
    Bertrand E
    World Health Forum; 1997; 18(2):163-5. PubMed ID: 9392999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What happened to the polypill?
    Watts G
    BMJ; 2008 Sep; 337():a1822. PubMed ID: 18819953
    [No Abstract]   [Full Text] [Related]  

  • 40. Time to implement the polypill approach.
    Holt S
    N Z Med J; 2009 Jun; 122(1296):88-9. PubMed ID: 19652688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.